Cristina Januario

Coimbra, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Longitudinal Dynamics of Polyglutamine-Expanded ATXN3 in Biofluids of Spinocerebellar Ataxia Type 3.

Longitudinal Dynamics of Polyglutamine-Expanded ATXN3 in Biofluids of Spinocerebellar Ataxia Type 3.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: March 30, 2026

The Medication Patterns of Spinocerebellar Ataxia Type 3 Mutation Carriers Enrolled in the ESMI Cohort.

The Medication Patterns of Spinocerebellar Ataxia Type 3 Mutation Carriers Enrolled in the ESMI Cohort.

Journal: CNS drugs

Published: April 26, 2025

Gut-first Parkinson's disease is encoded by gut dysbiome.

Gut-first Parkinson's disease is encoded by gut dysbiome.

Journal: Molecular neurodegeneration

Published: June 13, 2024

Indoleamine 2,3-dioxygenase (IDO1) - Can dendritic cells and monocytes expressing this moonlight enzyme change the phase of Parkinson's Disease?

Indoleamine 2,3-dioxygenase (IDO1) - Can dendritic cells and monocytes expressing this moonlight enzyme change the phase of Parkinson's Disease?

Journal: International immunopharmacology

Published: February 23, 2024

Assessing the impact of age on everyday cognitive function with a virtual environment task: The EcoKitchen.

Assessing the impact of age on everyday cognitive function with a virtual environment task: The EcoKitchen.

Journal: Applied neuropsychology. Adult

Published: October 17, 2023

Measuring cognitive impairment and monitoring cognitive decline in Huntington's disease: a comparison of assessment instruments.

Measuring cognitive impairment and monitoring cognitive decline in Huntington's disease: a comparison of assessment instruments.

Journal: Journal of neurology

Published: April 14, 2023

A standardised protocol for blood and cerebrospinal fluid collection and processing for biomarker research in ataxia.

A standardised protocol for blood and cerebrospinal fluid collection and processing for biomarker research in ataxia.

Journal: Neuropathology and applied neurobiology

Published: December 02, 2022

Trial of Deferiprone in Parkinson's Disease.

Trial of Deferiprone in Parkinson's Disease.

Journal: The New England journal of medicine

Published: November 30, 2022

Mitochondrial and redox modifications in early stages of Huntington's disease.

Mitochondrial and redox modifications in early stages of Huntington's disease.

Journal: Redox biology

Published: July 18, 2022

Classification of Huntington's Disease Stage with Features Derived from Structural and Diffusion-Weighted Imaging.

Classification of Huntington's Disease Stage with Features Derived from Structural and Diffusion-Weighted Imaging.

Journal: Journal of personalized medicine

Published: March 30, 2022

Defective mitochondria-lysosomal axis enhances the release of extracellular vesicles containing mitochondrial DNA and proteins in Huntington's disease.

Defective mitochondria-lysosomal axis enhances the release of extracellular vesicles containing mitochondrial DNA and proteins in Huntington's disease.

Journal: Journal of extracellular biology

Published: March 16, 2022

Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3.

Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3.

Journal: European journal of neurology

Published: February 22, 2022

Showing 1-12 of 58

Last Updated: 09/26/2026